AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0130
-0.0010 (-7.14%)
Feb 12, 2026, 1:37 PM EST

AXIM Biotechnologies Revenue

AXIM Biotechnologies had revenue of $17.48K in the quarter ending June 30, 2024, with 76.04% growth. This brings the company's revenue in the last twelve months to $92.90K, up 257.95% year-over-year. In the year 2023, AXIM Biotechnologies had annual revenue of $39.52K with 345.27% growth.

Revenue (ttm)
92.90K
Revenue Growth
+257.95%
P/S Ratio
49.80
Revenue / Employee
13.27K
Employees
7
Market Cap
4.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202339.52K30.64K345.27%
Dec 31, 20228.88K-51.59K-85.32%
Dec 31, 202160.46K--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
LakeShore Biopharma84.75M
Clearside Biomedical3.33M
Vaccinex601.00K
GPL Holdings376.54K
Enzolytics46.59K
Enzon Pharmaceuticals26.00K
Revenue Rankings